Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients. [electronic resource] by
- Joshi, Avadhut D
- Botham, Rachel C
- Schlein, Lisa J
- Roth, Howard S
- Mangraviti, Antonella
- Borodovsky, Alexandra
- Tyler, Betty
- Joslyn, Steve
- Looper, Jayme S
- Podell, Michael
- Fan, Timothy M
- Hergenrother, Paul J
- Riggins, Gregory J
Publication details: Oncotarget Oct 2017
In:
Oncotarget vol. 8
Availability: No items available.
|